Corient Ia LLC Gilead Sciences, Inc. Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
A detailed history of Corient Ia LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Corient Ia LLC holds 4,000 shares of GILD stock, worth $415,280. This represents 0.32% of its overall portfolio holdings.
Number of Shares
4,000Holding current value
$415,280% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,224Shares Held
984MCall Options Held
8.53MPut Options Held
8.9M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.27 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...